Heterogeneity of anti-dementia drug response in Alzheimer type dementia

Author： Gavrilova S.I. Seleznyova N.D. Kolykhalov I.V. Mikhailova N.M. Roschina I.F. Kalyn Y.B. Zharikov G.A.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 386-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Problems of heterogeneity in dementia of Alzheimer type: a computerized tomography study

By Kolykhalov I.V. Gavrilova S.I. Seleznyova N.D.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 384-384

Elsevier

Access to resources Recommend Favorite

Rivastigmine Transdermal Patch: In the Treatment of Dementia of the Alzheimer's Type

By Yang Lily P.H. Keating Gillian M.

CNS Drugs, Vol. 21, Iss. 11, 2007-01 ,pp. : 957-965

Adis International

Access to resources Recommend Favorite

Spotlight on Rivastigmine Transdermal Patch†: In Dementia of the Alzheimer's Type

By Dhillon Sohita

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 927-930

Adis International

Access to resources Recommend Favorite

Response to selegiline (I-deprenyl) in senile dementia of Alzheimer type: relation to disease stage

By Klashka J. Filip V. David I.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 388-388

Elsevier

Access to resources Recommend Favorite

Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?

By Liberini P. Valerio A. Memo M. Spano P.

Trends in Pharmacological Sciences, Vol. 17, Iss. 4, 1996-04 ,pp. : 155-160

Elsevier

Access to resources Recommend Favorite